DEF 14ACIK 0001173313

ABVC BIOPHARMA, INC. (ABVC, ECOC)

Name: SEC EDGAR filing 0001213900-26-104509
Creator: ABVC BIOPHARMA, INC. (ABVC, ECOC)
License: https://www.usa.gov/government-works

Proxy statement (DEF 14A) filed September 29, 2026.

Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.

Open the filing on SEC.gov

New to the DEF 14A? What it is and how to read one

Filing facts

Accession number: 0001213900-26-104509
Filer: ABVC BIOPHARMA, INC. (ABVC, ECOC)
CIK: 0001173313
Form type: DEF 14A
Form description: Proxy statement
Filed at: September 29, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: September 29, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1173313/000121390026104509/0001213900-26-104509-index.htm ↗

Filer's full EDGAR submission history

EDGAR · ABVC BIOPHARMA, INC. (ABVC, ECOC) (0001173313) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001213900-26-104509.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.